Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl ETHYPHARM for Breakthrough Cancer Pain
NCT01842893Phase 3Completed
- Sponsor
- Ethypharm
- Start
- Nov 2011
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in breakthrough pain, sponsored by Ethypharm. Started Nov 2011; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT01842893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01842893.